{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:57:47Z","timestamp":1747169867620,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.radcr.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T21:29:32Z","timestamp":1721856572000},"page":"4273-4279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cephalic and ocular manifestations of EBV-associated plasmablastic lymphoma: Clinical and radiological response to bortezomib, EPOCH, and intrathecal methotrexate"],"prefix":"10.1016","volume":"19","author":[{"given":"Bassam","family":"Theodory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skyler","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3527-151X","authenticated-orcid":false,"given":"Vivek V.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry I.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Bhanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duy Quang","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radcr.2024.07.011_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-015-0163-z","article-title":"Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients","volume":"8","author":"Loghavi","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/j.radcr.2024.07.011_bib0002","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.radcr.2024.07.011_bib0003","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.1097\/MD.0000000000005981","article-title":"Plasmablastic lymphoma","volume":"96","author":"Han","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.radcr.2024.07.011_bib0004","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.radcr.2024.07.011_bib0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1100\/tsw.2011.59","article-title":"Plasmablastic lymphoma: a systematic review","volume":"11","author":"Castillo","year":"2011","journal-title":"Scientific World Jl"},{"key":"10.1016\/j.radcr.2024.07.011_bib0006","unstructured":"Stein, H, Harris, N, & Campo, E. (2008). Plasmablastic lymphoma. In: WHO classification of tumours of the haematopoietic and lymphoid tissues (pp. 256\u2013257). IARC, Lyon."},{"issue":"20","key":"10.1016\/j.radcr.2024.07.011_bib0007","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"},{"year":"2022","series-title":"Plasmablastic lymphoma","author":"Bhatt","key":"10.1016\/j.radcr.2024.07.011_bib0008"},{"key":"10.1016\/j.radcr.2024.07.011_bib0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/BLCTT.S142814","article-title":"Plasmablastic lymphoma: current perspectives","volume":"8","author":"Lopez","year":"2018","journal-title":"Blood Lymphat Cancer"},{"year":"2021","series-title":"Atlas of diagnostic hematology","author":"Salama","key":"10.1016\/j.radcr.2024.07.011_bib0010"},{"issue":"6","key":"10.1016\/j.radcr.2024.07.011_bib0011","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0714.2006.00422.x","article-title":"Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma","volume":"35","author":"Lee","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.radcr.2024.07.011_bib0012","doi-asserted-by":"crossref","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","article-title":"Hodgkin lymphoma, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Hoppe","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radcr.2024.07.011_bib0013","unstructured":"NCCN Practice Guidelines in Oncology. AIDS-related B-cell lymphomas (AIDS-2), 2010. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/nhl.pdf."},{"issue":"5","key":"10.1016\/j.radcr.2024.07.011_bib0014","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.clml.2014.03.002","article-title":"Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review","volume":"14","author":"Cao","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.radcr.2024.07.011_bib0015","first-page":"287","article-title":"Bortezomib in plasmablastic lymphoma: a case report and review of the literature","volume":"36","author":"Saba","year":"2013","journal-title":"Onkologie"},{"issue":"1","key":"10.1016\/j.radcr.2024.07.011_bib0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/ejh.12286","article-title":"CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab","volume":"93","author":"Yan","year":"2014","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.radcr.2024.07.011_bib0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hon.2024","article-title":"Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib","volume":"31","author":"Dasanu","year":"2013","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.radcr.2024.07.011_bib0018","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.3816\/CLML.2010.n.074","article-title":"Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma","volume":"10","author":"Lipstein","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.radcr.2024.07.011_bib0019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2009.01235.x","article-title":"AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib","volume":"82","author":"Bose","year":"2009","journal-title":"Eur J Haematol"},{"issue":"34","key":"10.1016\/j.radcr.2024.07.011_bib0020","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1200\/JCO.2010.30.0038","article-title":"Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone","volume":"28","author":"Bibas","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324005995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324005995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:05:01Z","timestamp":1733231101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043324005995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1930043324005995"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2024.07.011","relation":{},"ISSN":["1930-0433"],"issn-type":[{"type":"print","value":"1930-0433"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cephalic and ocular manifestations of EBV-associated plasmablastic lymphoma: Clinical and radiological response to bortezomib, EPOCH, and intrathecal methotrexate","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}